Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLE.
Xinyi ZhuYashuo ChenZhihua YinYutong ZhangYiwei ShenDai DaiXiaojing LinLing-Hua ZouNan ShenZhizhong YeHuihua DingGuojun HouPublished in: Lupus science & medicine (2024)
RP11-273G15.2 could act as a diagnostic and disease activity monitoring biomarker for SLE, which might have the potential to guide clinical management.